Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

A Rare Case of Vancomycin-Induced Linear Immunoglobulin A Bullous Dermatosis.

Jha P, Swanson K, Stromich J, Michalski BM, Olasz E.

Case Rep Dermatol Med. 2017;2017:7318305. doi: 10.1155/2017/7318305.

2.

Incidence of and Risk Factors for Skin Cancer in Organ Transplant Recipients in the United States.

Garrett GL, Blanc PD, Boscardin J, Lloyd AA, Ahmed RL, Anthony T, Bibee K, Breithaupt A, Cannon J, Chen A, Cheng JY, Chiesa-Fuxench Z, Colegio OR, Curiel-Lewandrowski C, Del Guzzo CA, Disse M, Dowd M, Eilers R Jr, Ortiz AE, Morris C, Golden SK, Graves MS, Griffin JR, Hopkins RS, Huang CC, Bae GH, Jambusaria A, Jennings TA, Jiang SI, Karia PS, Khetarpal S, Kim C, Klintmalm G, Konicke K, Koyfman SA, Lam C, Lee P, Leitenberger JJ, Loh T, Lowenstein S, Madankumar R, Moreau JF, Nijhawan RI, Ochoa S, Olasz EB, Otchere E, Otley C, Oulton J, Patel PH, Patel VA, Prabhu AV, Pugliano-Mauro M, Schmults CD, Schram S, Shih AF, Shin T, Soon S, Soriano T, Srivastava D, Stein JA, Sternhell-Blackwell K, Taylor S, Vidimos A, Wu P, Zajdel N, Zelac D, Arron ST.

JAMA Dermatol. 2017 Jan 11. doi: 10.1001/jamadermatol.2016.4920. [Epub ahead of print]

PMID:
28097368
3.

Painful skin lesions and squamous cell carcinoma predict overall mortality risk in organ transplant recipients: A cohort study.

Oh CC, Hofbauer GF, Serra AL, Harwood CA, Mitchell L, Proby CM, Olasz EB, Mosel DD, Piaserico S, Fortina AB, Geusau A, Jahn-Bassler K, Gerritsen MJ, Seçkin D, Güleç AT, Cetkovská P, Ricar J, Imko-Walczuk B, Dębska-Ślizień A, Bouwes Bavinck JN.

Br J Dermatol. 2016 Dec 23. doi: 10.1111/bjd.15269. [Epub ahead of print]

PMID:
28012178
4.

Electrochemotherapy - yet another innovative application.

Olasz EB, Kis E.

Br J Dermatol. 2016 Dec;175(6):1148-1149. doi: 10.1111/bjd.14902. No abstract available.

PMID:
27996120
5.

What You Didn't Know About the Sun: Infrared Radiation and Its Role in Photoaging.

Michalski B, Olasz E.

Plast Surg Nurs. 2016 Oct/Dec;36(4):170-172. No abstract available.

PMID:
27922560
6.

Successful Treatment of Recalcitrant Plantar Warts With Bleomycin and Microneedling.

Konicke K, Olasz E.

Dermatol Surg. 2016 Aug;42(8):1007-8. doi: 10.1097/DSS.0000000000000738. No abstract available.

PMID:
27227479
7.

Building a global teledermatology collaboration.

Bobbs M, Bayer M, Frazer T, Humphrey S, Wilson B, Olasz E, Holland K, Kuzminski J.

Int J Dermatol. 2016 Apr;55(4):446-9. doi: 10.1111/ijd.13223.

PMID:
26873427
8.

MicroRNA-135b Regulates Leucine Zipper Tumor Suppressor 1 in Cutaneous Squamous Cell Carcinoma.

Olasz EB, Seline LN, Schock AM, Duncan NE, Lopez A, Lazar J, Flister MJ, Lu Y, Liu P, Sokumbi O, Harwood CA, Proby CM, Neuburg M, Lazarova Z.

PLoS One. 2015 May 4;10(5):e0125412. doi: 10.1371/journal.pone.0125412.

9.

Eruptive keratoacanthomas after radiation therapy for keratoacanthoma centrifugum marginatum.

Lindsay DP, Kharofa J, Junck M, Olasz E, Wilson JF.

Pract Radiat Oncol. 2015 May-Jun;5(3):203-6. No abstract available.

PMID:
25432542
10.

Pain identifies squamous cell carcinoma in organ transplant recipients: the SCOPE-ITSCC PAIN study.

Bouwes Bavinck JN, Harwood CA, Genders RE, Wisgerhof HC, Plasmeijer EI, Mitchell L, Olasz EB, Mosel DD, Pokorney MS, Serra AL, Feldmeyer L, Baumann Conzett K, Piaserico S, Belloni Fortina A, Jahn K, Geusau A, Gerritsen MJ, Seckin D, Gulec AT, Cetkovska P, Ricar J, Imko-Walczuk B, Proby CM, Hofbauer GF.

Am J Transplant. 2014 Mar;14(3):668-76.

PMID:
24730051
11.

EGFRvIII expression in squamous cell carcinoma of the skin.

Dziunycz PJ, Lazarova Z, Duncan N, Wong S, Neuburg M, Hofbauer GF, Olasz EB.

JAMA Dermatol. 2013 Oct;149(10):1240-2. doi: 10.1001/jamadermatol.2013.5230. No abstract available.

PMID:
23986462
12.

Sirolimus reduces cutaneous squamous cell carcinomas in transplantation recipients.

Colegio OR, Hanlon A, Olasz EB, Carucci JA.

J Clin Oncol. 2013 Sep 10;31(26):3297-8. doi: 10.1200/JCO.2013.50.6840. No abstract available.

PMID:
23918945
13.

Disseminated Nocardia infection presenting as hemorrhagic pustules and ecthyma in a woman with systemic lupus erythematosus and antiphospholipid antibody syndrome.

Mosel D, Harris L, Fisher E, Olasz E, Wilson B.

J Dermatol Case Rep. 2013 Jun 30;7(2):52-5. doi: 10.3315/jdcr.2013.1142.

14.

A synthetic superoxide dismutase/catalase mimetic EUK-207 mitigates radiation dermatitis and promotes wound healing in irradiated rat skin.

Doctrow SR, Lopez A, Schock AM, Duncan NE, Jourdan MM, Olasz EB, Moulder JE, Fish BL, Mäder M, Lazar J, Lazarova Z.

J Invest Dermatol. 2013 Apr;133(4):1088-96. doi: 10.1038/jid.2012.410. Erratum in: J Invest Dermatol. 2013 Jun;133(6):1691.

15.

Clinical regression of squamous cell carcinoma and keratoacanthomas in a patient treated with a hypomethylating agent.

Randhawa J, Wong S, Atallah E, Olasz E.

Int J Dermatol. 2014 Jan;53(1):e13-4. doi: 10.1111/j.1365-4632.2011.05350.x. No abstract available.

PMID:
22998756
16.

Two-dimensional dielectric imaging for dermatologic screening: a feasibility study.

Habibi M, Olasz EB, Klemer DP.

Skin Res Technol. 2012 Aug;18(3):324-31. doi: 10.1111/j.1600-0846.2011.00566.x.

PMID:
22092364
17.

Laminin 332 deposition is diminished in irradiated skin in an animal model of combined radiation and wound skin injury.

Jourdan MM, Lopez A, Olasz EB, Duncan NE, Demara M, Kittipongdaja W, Fish BL, Mäder M, Schock A, Morrow NV, Semenenko VA, Baker JE, Moulder JE, Lazarova Z.

Radiat Res. 2011 Nov;176(5):636-48.

18.

Sequential intramolecular epitope spreading of humoral responses to human BPAG2 in a transgenic model.

Di Zenzo G, Calabresi V, Olasz EB, Zambruno G, Yancey KB.

J Invest Dermatol. 2010 Apr;130(4):1040-7. doi: 10.1038/jid.2009.309.

19.

A novel humanized neonatal autoimmune blistering skin disease model induced by maternally transferred antibodies.

Nishie W, Sawamura D, Natsuga K, Shinkuma S, Goto M, Shibaki A, Ujiie H, Olasz E, Yancey KB, Shimizu H.

J Immunol. 2009 Sep 15;183(6):4088-93. doi: 10.4049/jimmunol.0800389.

20.

Transient anti-CD40L co-stimulation blockade prevents immune responses against human bullous pemphigoid antigen 2: implications for gene therapy.

Lanschuetzer CM, Olasz EB, Lazarova Z, Yancey KB.

J Invest Dermatol. 2009 May;129(5):1203-7. doi: 10.1038/jid.2008.364.

Items per page

Supplemental Content

Support Center